Global Dermatological Drugs Market Size study & Forecast, by Indication (Acne, Psoriasis, Rosacea, Alopecia, Others) and Regional Analysis, 2022-2029
Global Dermatological Drugs Market is valued at approximately USD 17.0 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 10.8% over the forecast period 2022-2029. Dermatological drugs are medical substances used to treat a variety of skin disorders and their direct concern is skin care. Various skin disorders such as Acne, Alopecia Areata, Pemphigus, and more are treated through dermatological drugs. The focus of Dermatological drugs is to cure and prevent skin disorders. Increasing skin conditions, growing awareness regarding skin diseases, increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income are the factors driving the growth of the market.
According to Health, Pharma & MedTech, in India, around 23% of the respondents suffered from skin conditions such as acne and dandruff in 2021. According to the American Academy of Dermatology Association, around 85% of adult people aged between 12 to 24 experience minor acne. The increasing prevalence of skin conditions results in the growth of the dermatological drugs market. Additionally, the global skin treatment in 2023 was valued at around 18.71 billion, most of which is generated in the US. Increasing treatment of skin conditions shows the increasing awareness of skin diseases which drives the market growth. Other important components driving market increase are increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income. Furthermore, an increase in healthcare expenditure and the Development of the pharmaceutical industry are the factors creating major market opportunities. However, the availability of alternatives stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Dermatological Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the high number of patients with skin diseases, increasing underground hydrogen storage adoption, increasing government investment in the development of hydrogen storage capacities, rising investments in the healthcare sector, and the region's increasing investment in hydrogen energy. North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as technological advancements, real-time data delivery, Increasing awareness regarding the adoption of natural gas and, supportive government regulations
Major market player included in this report are:
Novartis AG
Amgen Inc
AbbVie Inc
Johnson & Johnson Private Limited
Leo Pharma A/S
Eli Lilly and Company
GlaxoSmithKline Plc
AstraZeneca plc
Pfizer Inc
Merck KGaA
Recent Developments in the Market:
In July 2021, TWYNEO cream of Sol-Gel Technologies Ltd was approved by US FDA for the treatment of acne vulgaris.
In June 2021, Kyowa Kirin Co., Ltd. and Amgen have agreed to work together to develop and market KHK4083 for the treatment of skin diseases such as atopic dermatitis.
Global Dermatological Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Indication, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Indication offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Acne
Psoriasis
Rosacea
Alopecia
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
According to Health, Pharma & MedTech, in India, around 23% of the respondents suffered from skin conditions such as acne and dandruff in 2021. According to the American Academy of Dermatology Association, around 85% of adult people aged between 12 to 24 experience minor acne. The increasing prevalence of skin conditions results in the growth of the dermatological drugs market. Additionally, the global skin treatment in 2023 was valued at around 18.71 billion, most of which is generated in the US. Increasing treatment of skin conditions shows the increasing awareness of skin diseases which drives the market growth. Other important components driving market increase are increasing demand for innovative products, approval of drugs for treatment, increasing investment in research and development, and increasing disposable income. Furthermore, an increase in healthcare expenditure and the Development of the pharmaceutical industry are the factors creating major market opportunities. However, the availability of alternatives stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Dermatological Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Europe dominated the market in terms of revenue, owing to the high number of patients with skin diseases, increasing underground hydrogen storage adoption, increasing government investment in the development of hydrogen storage capacities, rising investments in the healthcare sector, and the region's increasing investment in hydrogen energy. North America is expected to grow with the highest CAGR during the forecast period, owing to factors such as technological advancements, real-time data delivery, Increasing awareness regarding the adoption of natural gas and, supportive government regulations
Major market player included in this report are:
Novartis AG
Amgen Inc
AbbVie Inc
Johnson & Johnson Private Limited
Leo Pharma A/S
Eli Lilly and Company
GlaxoSmithKline Plc
AstraZeneca plc
Pfizer Inc
Merck KGaA
Recent Developments in the Market:
In July 2021, TWYNEO cream of Sol-Gel Technologies Ltd was approved by US FDA for the treatment of acne vulgaris.
In June 2021, Kyowa Kirin Co., Ltd. and Amgen have agreed to work together to develop and market KHK4083 for the treatment of skin diseases such as atopic dermatitis.
Global Dermatological Drugs Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Indication, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Indication offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Indication:
Acne
Psoriasis
Rosacea
Alopecia
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Dermatological Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Dermatological Drugs Market, by Indication, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DERMATOLOGICAL DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DERMATOLOGICAL DRUGS MARKET DYNAMICS
3.1. Dermatological Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing skin conditions
3.1.1.2. Growing awareness regarding skin diseases
3.1.2. Market Challenges
3.1.2.1. Availability of alternatives
3.1.3. Market Opportunities
3.1.3.1. Increase in healthcare expenditure
3.1.3.2. Development of the pharmaceutical industry
CHAPTER 4. GLOBAL DERMATOLOGICAL DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL DERMATOLOGICAL DRUGS MARKET, BY INDICATION
6.1. Market Snapshot
6.2. Global Dermatological Drugs Market by Indication, Performance - Potential Analysis
6.3. Global Dermatological Drugs Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Dermatological Drugs Market, Sub Segment Analysis
6.4.1. Acne
6.4.2. Psoriasis
6.4.3. Rosacea
6.4.4. Alopecia
6.4.5. Others
CHAPTER 7. GLOBAL DERMATOLOGICAL DRUGS MARKET, REGIONAL ANALYSIS
7.1. Dermatological Drugs Market, Regional Market Snapshot
7.2. North America Dermatological Drugs Market
7.2.1. U.S. Dermatological Drugs Market
7.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Dermatological Drugs Market
7.3. Europe Dermatological Drugs Market Snapshot
7.3.1. U.K. Dermatological Drugs Market
7.3.2. Germany Dermatological Drugs Market
7.3.3. France Dermatological Drugs Market
7.3.4. Spain Dermatological Drugs Market
7.3.5. Italy Dermatological Drugs Market
7.3.6. Rest of Europe Dermatological Drugs Market
7.4. Asia-Pacific Dermatological Drugs Market Snapshot
7.4.1. China Dermatological Drugs Market
7.4.2. India Dermatological Drugs Market
7.4.3. Japan Dermatological Drugs Market
7.4.4. Australia Dermatological Drugs Market
7.4.5. South Korea Dermatological Drugs Market
7.4.6. Rest of Asia Pacific Dermatological Drugs Market
7.5. Latin America Dermatological Drugs Market Snapshot
7.5.1. Brazil Dermatological Drugs Market
7.5.2. Mexico Dermatological Drugs Market
7.6. Rest of The World Dermatological Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Novartis AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Amgen Inc
8.2.3. AbbVie Inc
8.2.4. Johnson & Johnson Private Limited
8.2.5. Leo Pharma A/S
8.2.6. Eli Lilly and Company
8.2.7. GlaxoSmithKline Plc
8.2.8. AstraZeneca plc
8.2.9. Pfizer Inc
8.2.10. Merck KGaA
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Dermatological Drugs Market, by Region, 2019-2029 (USD Billion)
1.2.2. Dermatological Drugs Market, by Indication, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL DERMATOLOGICAL DRUGS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL DERMATOLOGICAL DRUGS MARKET DYNAMICS
3.1. Dermatological Drugs Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing skin conditions
3.1.1.2. Growing awareness regarding skin diseases
3.1.2. Market Challenges
3.1.2.1. Availability of alternatives
3.1.3. Market Opportunities
3.1.3.1. Increase in healthcare expenditure
3.1.3.2. Development of the pharmaceutical industry
CHAPTER 4. GLOBAL DERMATOLOGICAL DRUGS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL DERMATOLOGICAL DRUGS MARKET, BY INDICATION
6.1. Market Snapshot
6.2. Global Dermatological Drugs Market by Indication, Performance - Potential Analysis
6.3. Global Dermatological Drugs Market Estimates & Forecasts by Indication 2019-2029 (USD Billion)
6.4. Dermatological Drugs Market, Sub Segment Analysis
6.4.1. Acne
6.4.2. Psoriasis
6.4.3. Rosacea
6.4.4. Alopecia
6.4.5. Others
CHAPTER 7. GLOBAL DERMATOLOGICAL DRUGS MARKET, REGIONAL ANALYSIS
7.1. Dermatological Drugs Market, Regional Market Snapshot
7.2. North America Dermatological Drugs Market
7.2.1. U.S. Dermatological Drugs Market
7.2.1.1. Indication breakdown estimates & forecasts, 2019-2029
7.2.2. Canada Dermatological Drugs Market
7.3. Europe Dermatological Drugs Market Snapshot
7.3.1. U.K. Dermatological Drugs Market
7.3.2. Germany Dermatological Drugs Market
7.3.3. France Dermatological Drugs Market
7.3.4. Spain Dermatological Drugs Market
7.3.5. Italy Dermatological Drugs Market
7.3.6. Rest of Europe Dermatological Drugs Market
7.4. Asia-Pacific Dermatological Drugs Market Snapshot
7.4.1. China Dermatological Drugs Market
7.4.2. India Dermatological Drugs Market
7.4.3. Japan Dermatological Drugs Market
7.4.4. Australia Dermatological Drugs Market
7.4.5. South Korea Dermatological Drugs Market
7.4.6. Rest of Asia Pacific Dermatological Drugs Market
7.5. Latin America Dermatological Drugs Market Snapshot
7.5.1. Brazil Dermatological Drugs Market
7.5.2. Mexico Dermatological Drugs Market
7.6. Rest of The World Dermatological Drugs Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Novartis AG
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Amgen Inc
8.2.3. AbbVie Inc
8.2.4. Johnson & Johnson Private Limited
8.2.5. Leo Pharma A/S
8.2.6. Eli Lilly and Company
8.2.7. GlaxoSmithKline Plc
8.2.8. AstraZeneca plc
8.2.9. Pfizer Inc
8.2.10. Merck KGaA
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Dermatological Drugs Market, report scope
TABLE 2. Global Dermatological Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Dermatological Drugs Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 4. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Dermatological Drugs Market
TABLE 69. List of primary sources, used in the study of global Dermatological Drugs Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Dermatological Drugs Market, report scope
TABLE 2. Global Dermatological Drugs Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Dermatological Drugs Market estimates & forecasts by Indication 2019-2029 (USD Billion)
TABLE 4. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 5. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Dermatological Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Dermatological Drugs Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. U.S. Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 16. U.S. Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. Canada Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 18. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. UK Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 21. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. Germany Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 24. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. France Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 27. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. Italy Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 30. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Spain Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 33. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. RoE Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 36. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. China Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 39. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. India Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 42. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. Japan Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 45. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. South Korea Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 48. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. Australia Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 51. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. RoAPAC Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 54. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. Brazil Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 57. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Mexico Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 60. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. RoLA Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 63. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. Row Dermatological Drugs Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 66. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Dermatological Drugs Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. List of secondary sources, used in the study of global Dermatological Drugs Market
TABLE 69. List of primary sources, used in the study of global Dermatological Drugs Market
TABLE 70. Years considered for the study
TABLE 71. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Dermatological Drugs Market, research methodology
FIG 2. Global Dermatological Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Dermatological Drugs Market, key trends 2021
FIG 5. Global Dermatological Drugs Market, growth prospects 2022-2029
FIG 6. Global Dermatological Drugs Market, porters 5 force model
FIG 7. Global Dermatological Drugs Market, pest analysis
FIG 8. Global Dermatological Drugs Market, value chain analysis
FIG 9. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Dermatological Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Dermatological Drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Dermatological Drugs Market, research methodology
FIG 2. Global Dermatological Drugs Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Dermatological Drugs Market, key trends 2021
FIG 5. Global Dermatological Drugs Market, growth prospects 2022-2029
FIG 6. Global Dermatological Drugs Market, porters 5 force model
FIG 7. Global Dermatological Drugs Market, pest analysis
FIG 8. Global Dermatological Drugs Market, value chain analysis
FIG 9. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Dermatological Drugs Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Dermatological Drugs Market, regional snapshot 2019 & 2029
FIG 15. North America Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 16. Europe Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Dermatological Drugs Market 2019 & 2029 (USD Billion)
FIG 19. Global Dermatological Drugs Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
